Physician profile
Dina C Blom
NPI 1235106279
$1,488.99
in general payments reported to CMS, 2019-2025
16 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $514 · 2020: $36.00 · 2021: $64.03 · 2022: $380 · 2023: $63.80 · 2024: $164 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $546.89 | 2019-2025 | Rocklatan, Clareon |
| Johnson & Johnson Surgical Vision, INC. | $216.93 | 2019-2025 | Tecnis Simplicity |
| Histosonics, INC. | $141.88 | 2025 | |
| Biotissue Holdings INC. | $129.49 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $76.25 | 2022-2025 | Vyzulta, Miebo, Envista Envy Iol |
| Abbvie INC. | $73.71 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $51.75 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $51.40 | 2024-2025 | Acthar |
| Thea Pharma INC. | $43.62 | 2024 | Iyuzeh |
| Amgen INC. | $35.63 | 2024-2025 | Tepezza |
| Allergan, INC. | $32.57 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $22.26 | 2022 | |
| Aerie Pharmaceuticals, INC. | $18.02 | 2019 | |
| Oyster Point Pharma, INC. | $17.66 | 2023 | Tyrvaya |
| Rxsight INC | $16.82 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $14.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dina Blom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.